United States · Bill · HR
H.R. 4151 (103rd)
Essential Pharmaceuticals Act of 1994
Introduced
24 March 1994
Last action
—
Status
Referred to the Subcommittee on Intellectual Property and Judicial Administration.
Sponsors
—
Subjects
Discovery layer
Source updated
26 August 2025
Summary
Essential Pharmaceuticals Act of 1994 - Directs the Secretary of Health and Human Services to notify the Commissioner of Patents and Trademarks if the Secretary determines that the owner of a patent which claims a product or a method of using or manufacturing a product and which may be extended has not taken all reasonable steps toward the commercial marketing or use of that product whose availability to the public is of vital importance to the public health or welfare. Requires the Commissioner to provide for the compulsory licensing of all patents relating to that product. Allows an individual aggrieved by a decision of: (1) the Commissioner under this Act to appeal that decision to the Board of Patent Appeals and Interferences, after paying the fee for such appeal; and (2) the Board to appeal that decision to the United States Court of Appeals for the Federal Circuit.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 24 March 1994
Introduced in House (PDF)
Introduced in House · EN · 24 March 1994
Introduced in House
summary · EN · 24 March 1994
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/103rd-congress/house-bill/4151
- Open data entity: https://api.congress.gov/v3/bill/103/hr/4151